DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 886 filers reported holding DANAHER CORPORATION in Q3 2014. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,108,958 | -16.1% | 42,617 | +0.2% | 1.98% | -15.5% |
| Q2 2023 | $10,860,969 | -0.6% | 42,522 | -1.9% | 2.34% | -2.3% |
| Q1 2023 | $10,923,666 | -7.1% | 43,341 | -2.1% | 2.40% | -8.9% |
| Q4 2022 | $11,752,267 | +2.5% | 44,278 | -0.3% | 2.63% | -4.3% |
| Q3 2022 | $11,470,000 | +1.5% | 44,407 | -0.4% | 2.75% | +9.3% |
| Q2 2022 | $11,302,000 | -13.8% | 44,582 | -0.3% | 2.52% | +0.4% |
| Q1 2022 | $13,115,000 | -11.8% | 44,711 | -1.1% | 2.51% | -5.0% |
| Q4 2021 | $14,871,000 | +3.2% | 45,199 | -4.6% | 2.64% | -3.5% |
| Q3 2021 | $14,416,000 | +11.7% | 47,354 | -1.5% | 2.73% | +11.4% |
| Q2 2021 | $12,904,000 | +18.0% | 48,085 | -1.1% | 2.45% | +9.9% |
| Q1 2021 | $10,939,000 | -1.7% | 48,604 | -3.0% | 2.23% | -5.5% |
| Q4 2020 | $11,132,000 | +2.9% | 50,113 | -0.2% | 2.36% | -24.4% |
| Q3 2020 | $10,816,000 | +17.1% | 50,228 | -3.8% | 3.13% | +7.4% |
| Q2 2020 | $9,236,000 | +26.3% | 52,231 | -1.2% | 2.91% | +6.3% |
| Q1 2020 | $7,315,000 | -12.9% | 52,850 | -3.4% | 2.74% | +13.6% |
| Q4 2019 | $8,397,000 | +5.2% | 54,709 | -1.0% | 2.41% | -0.4% |
| Q3 2019 | $7,979,000 | -4.2% | 55,245 | -5.2% | 2.42% | +2.7% |
| Q2 2019 | $8,332,000 | +7.2% | 58,301 | -1.0% | 2.36% | +8.2% |
| Q1 2019 | $7,773,000 | -37.3% | 58,881 | -51.0% | 2.18% | +11.0% |
| Q4 2018 | $12,389,000 | +85.8% | 120,142 | +95.8% | 1.96% | +2.3% |
| Q3 2018 | $6,667,000 | +9.9% | 61,361 | -0.2% | 1.92% | +3.7% |
| Q2 2018 | $6,066,000 | -0.2% | 61,476 | -0.9% | 1.85% | -5.1% |
| Q1 2018 | $6,077,000 | +4.1% | 62,064 | -1.3% | 1.95% | +8.3% |
| Q4 2017 | $5,836,000 | -1.6% | 62,879 | -2.2% | 1.80% | -3.1% |
| Q3 2017 | $5,932,000 | +10.1% | 64,289 | +0.7% | 1.86% | +4.7% |
| Q2 2017 | $5,389,000 | -1.8% | 63,864 | -0.5% | 1.78% | -3.8% |
| Q1 2017 | $5,489,000 | +7.9% | 64,179 | -1.8% | 1.84% | -2.5% |
| Q4 2016 | $5,087,000 | -2.2% | 65,349 | -1.8% | 1.89% | +2.5% |
| Q3 2016 | $5,204,000 | -24.7% | 66,529 | -2.7% | 1.85% | -29.4% |
| Q2 2016 | $6,909,000 | +5.4% | 68,404 | -1.0% | 2.61% | +1.9% |
| Q1 2016 | $6,556,000 | +2.7% | 69,109 | +0.5% | 2.57% | -0.9% |
| Q4 2015 | $6,386,000 | +3.0% | 68,754 | -5.5% | 2.59% | +3.9% |
| Q3 2015 | $6,201,000 | -0.5% | 72,768 | -0.1% | 2.49% | +7.9% |
| Q2 2015 | $6,234,000 | -1.1% | 72,833 | -1.9% | 2.31% | +2.1% |
| Q1 2015 | $6,303,000 | -3.1% | 74,244 | -2.2% | 2.26% | -12.8% |
| Q4 2014 | $6,505,000 | +5.8% | 75,899 | -0.8% | 2.59% | +5.5% |
| Q3 2014 | $6,151,000 | +2.0% | 76,499 | -0.1% | 2.46% | +0.8% |
| Q2 2014 | $6,030,000 | +9.2% | 76,589 | +4.0% | 2.44% | +2.6% |
| Q1 2014 | $5,522,000 | -7.9% | 73,629 | -5.2% | 2.38% | -5.9% |
| Q4 2013 | $5,996,000 | +6.5% | 77,674 | -4.4% | 2.53% | +2.9% |
| Q3 2013 | $5,630,000 | +6.0% | 81,224 | -3.2% | 2.46% | +5.0% |
| Q2 2013 | $5,313,000 | – | 83,929 | – | 2.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |